Form 4 Filing for BioCardia, Inc. - Simon H. Stertzer

This Form 4 filing details a transaction by Simon H. Stertzer, a director at BioCardia, Inc. (BCDA). On July 6, 2026, Mr. Stertzer was granted 8,000 stock options to acquire common stock, with an exercise price of $1.20 per share. These options vest and become exercisable one year from the grant date, provided Mr. Stertzer remains a service provider. The options have an expiration date of July 6, 2036. Following this transaction, Mr. Stertzer directly owns 23,573 shares of BioCardia, Inc. common stock.